오피니언 공유하기 기사 공유하기 페이스북 X(트위터) 카카오 텔레그램 네이버 밴드 링크복사 https://koreanewdaily.com/news/section_list_all.html?catid=Y 주소가 복사되었습니다.원하는 곳에 붙여넣기 하세요. 취재수첩 환자는 못 버틴다… 봉합 불발시 외국의사 당장 수입해야 전공의 처분 멈추면 의대교수 사직 철회할까… 산적한 변수 전국 곳곳 의대교수 집단사직 현실로… 봉쇄된 '봉합 출구' 전의교협 "진료축소 불가피… 돌아가시는 분 나오겠지만 의사도 사람"
What´s wrong with ILMN & PACB are they really undervalued Illumina: ‘Ichan doesn’t fully understand growth projections of this company,’ analyst says Illumina Stock: Innovation Fuels Growth - $ILMN Carl Icahn vs Illumina: Danger Ahead Illumina CEO Francis deSouza on Q1 earnings, Grail acquisition Illumina (ILMN) fails to impress. Grail still a major overhang. Illumina: Potential new catalyst and a trade idea. Biotech´s Illumina stock tumbles on weaker-than-expected profit outlook Illumina AI - ChatGPT for your genome... 4 Growth Stocks Trading at Reasonable Prices for Long-Term Investors GOP lawmakers, state AGs voice support for Illumina´s Grail acquisition I sold ILMN stock | Illumina stock update Illumina CEO deSouza resigns after proxy battle with Carl Icahn We were right about Illumina. Here´s how I see PACB now. Illumina (ILMN) Stock Analysis: Should You Invest